These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20307491)

  • 1. Cocaine produces D2R-mediated conformational changes in the adenosine A(2A)R-dopamine D2R heteromer.
    Marcellino D; Navarro G; Sahlholm K; Nilsson J; Agnati LF; Canela EI; Lluís C; Århem P; Franco R; Fuxe K
    Biochem Biophys Res Commun; 2010 Apr; 394(4):988-92. PubMed ID: 20307491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A serine point mutation in the adenosine A2AR C-terminal tail reduces receptor heteromerization and allosteric modulation of the dopamine D2R.
    Borroto-Escuela DO; Marcellino D; Narvaez M; Flajolet M; Heintz N; Agnati L; Ciruela F; Fuxe K
    Biochem Biophys Res Commun; 2010 Mar; 394(1):222-7. PubMed ID: 20197060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes.
    Torvinen M; Marcellino D; Canals M; Agnati LF; Lluis C; Franco R; Fuxe K
    Mol Pharmacol; 2005 Feb; 67(2):400-7. PubMed ID: 15539641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new D₂ dopamine receptor agonist allosterically modulates A(2A) adenosine receptor signalling by interacting with the A(2A)/D₂ receptor heteromer.
    Trincavelli ML; Daniele S; Orlandini E; Navarro G; Casadó V; Giacomelli C; Nencetti S; Nuti E; Macchia M; Huebner H; Gmeiner P; Rossello A; Lluís C; Martini C
    Cell Signal; 2012 Apr; 24(4):951-60. PubMed ID: 22230688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the existence of a possible A2A-D2-β-Arrestin2 complex: A2A agonist modulation of D2 agonist-induced β-arrestin2 recruitment.
    Borroto-Escuela DO; Romero-Fernandez W; Tarakanov AO; Ciruela F; Agnati LF; Fuxe K
    J Mol Biol; 2011 Mar; 406(5):687-99. PubMed ID: 21256133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in A2A receptors in the nucleus accumbens after extended cocaine self-administration and its disappearance after cocaine withdrawal.
    Marcellino D; Roberts DC; Navarro G; Filip M; Agnati L; Lluís C; Franco R; Fuxe K
    Brain Res; 2007 Apr; 1143():208-20. PubMed ID: 17320828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease.
    Tanganelli S; Sandager Nielsen K; Ferraro L; Antonelli T; Kehr J; Franco R; Ferré S; Agnati LF; Fuxe K; Scheel-Krüger J
    Parkinsonism Relat Disord; 2004 Jul; 10(5):273-80. PubMed ID: 15196505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cocaine self-administration and extinction on D2 -like and A2A receptor recognition and D2 -like/Gi protein coupling in rat striatum.
    Frankowska M; Marcellino D; Adamczyk P; Filip M; Fuxe K
    Addict Biol; 2013 May; 18(3):455-66. PubMed ID: 22500978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the A2AR-D2R interface: focus on the role of the C-terminal tail and the transmembrane helices.
    Borroto-Escuela DO; Romero-Fernandez W; Tarakanov AO; Gómez-Soler M; Corrales F; Marcellino D; Narvaez M; Frankowska M; Flajolet M; Heintz N; Agnati LF; Ciruela F; Fuxe K
    Biochem Biophys Res Commun; 2010 Nov; 402(4):801-7. PubMed ID: 21040702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive and synergistic signaling of human adenosine A2a and dopamine D2L receptors in CHO cells.
    Tang Y; Demarest KT
    J Recept Signal Transduct Res; 2005; 25(3):159-79. PubMed ID: 16194932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.
    Marcellino D; Carriba P; Filip M; Borgkvist A; Frankowska M; Bellido I; Tanganelli S; Müller CE; Fisone G; Lluis C; Agnati LF; Franco R; Fuxe K
    Neuropharmacology; 2008 Apr; 54(5):815-23. PubMed ID: 18262573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A2AR Transmembrane 2 Peptide Administration Disrupts the A2AR-A2AR Homoreceptor but Not the A2AR-D2R Heteroreceptor Complex: Lack of Actions on Rodent Cocaine Self-Administration.
    Borroto-Escuela DO; Wydra K; Romero-Fernandez W; Zhou Z; Frankowska M; Filip M; Fuxe K
    Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31816953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
    Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
    J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders.
    Ferré S; Ciruela F; Canals M; Marcellino D; Burgueno J; Casadó V; Hillion J; Torvinen M; Fanelli F; Benedetti Pd Pd; Goldberg SR; Bouvier M; Fuxe K; Agnati LF; Lluis C; Franco R; Woods A
    Parkinsonism Relat Disord; 2004 Jul; 10(5):265-71. PubMed ID: 15196504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
    Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-dependent oligomerization of dopamine D(2) and adenosine A(2A) receptors in living neuronal cells.
    Vidi PA; Chemel BR; Hu CD; Watts VJ
    Mol Pharmacol; 2008 Sep; 74(3):544-51. PubMed ID: 18524886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
    Millan MJ; Cussac D; Gobert A; Lejeune F; Rivet JM; Mannoury La Cour C; Newman-Tancredi A; Peglion JL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):903-20. PubMed ID: 14978194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity of A2A and especially D2 receptor trafficking to cocaine compared with lipid rafts in cotransfected CHO cell lines. Novel actions of cocaine independent of the DA transporter.
    Genedani S; Carone C; Guidolin D; Filaferro M; Marcellino D; Fuxe K; Agnati LF
    J Mol Neurosci; 2010 Jul; 41(3):347-57. PubMed ID: 20143275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers.
    Soriano A; Ventura R; Molero A; Hoen R; Casadó V; Cortés A; Fanelli F; Albericio F; Lluís C; Franco R; Royo M
    J Med Chem; 2009 Sep; 52(18):5590-602. PubMed ID: 19711895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.